Evaluate the Effect of Prone Ventilation on Ventilated-blood Flow Ratio in Patients With ARDS by EIT

Evaluate the Effect of Prone Ventilation on Ventilated-blood Flow Ratio in Patients With Acute Respiratory Distress Syndrome by Electrical Impedance Tomography

Patients with ARDS often suffer a gravity-dependent alveolar collapse, resulting in a reduction of tidal volume, residual alveolar excessive distension, and ventilator-related lung injury(VILI) induced by unreasonable ventilator setting.Prone ventilation (PPV) improves the gravity-dependent alveolar ventilation and promotes lung recruitment in the gravity-dependent area and improves lung compliance. Previous studies showed that prolonged PPV combined with low tidal volume(LTV) lung protected ventilation can significantly reduce the mortality of patients with moderate to severe ARDS.Although more than 60% of patients with moderate to severe ARDS due to COVID-19 has been widely implemented PPV,studies showed an improvement in oxygenation in patients with ARDS(the P/F radio improved by more than 20% before and after PPV) was 9-77%, that is, That is, some patients are unresponsive to PPV. In addition, some patients showed CO2 responsiveness after PPV(ventilation rate (VR) decreased significantly after PPV).The tools for monitoring the effects of PPV on ventilation and blood flow at bedside are still lacking, Electrical impedance tomography (EIT) is a non-invasive, non-radiative, real-time bedside lung imaging technique that can monitor local lung ventilation distribution. This study intends to use EIT to evaluate pulmonary ventilation, blood flow distribution and local V/Q ratio before and after PPV, as well as to monitor the changes in pulmonary physiology before and after PPV, explore the mechanism of PPV improving oxygenation by combined with the changes in oxygenation, and explore the factors that predict and affect PPV responsiveness.

Study Overview

Detailed Description

Acute respiratory distress syndrome (ARDS) is presented as acute hypoxemia and pulmonary edema due to the increased permeability of alveolar capillaries. Endothelial damage injury and swelling, microthrombosis, and hypoxic pulmonary vasoconstriction can lead to low pulmonary blood vessels perfusion and even occlusion, while patients with ARDS often suffer a gravity-dependent alveolar collapse, resulting in a reduction of tidal volume, residual alveolar excessive distension, and ventilator-related lung injury(VILI) induced by unreasonable ventilator setting.Prone ventilation (PPV) improves the gravity-dependent alveolar ventilation and promotes lung recruitment in the gravity-dependent area and improves lung compliance. Besides, pulmonary blood perfusion is less affected by gravity distribution, thus the improvement of gravity-dependent alveolar ventilation can significantly reduce shunt, and lung heterogeneity and improve V/Q radio. Previous studies showed that prolonged PPV combined with low tidal volume lung protected ventilation can significantly reduce the mortality of patients with moderate to severe ARDS.Although more than 60% of patients with moderate to severe ARDS due to COVID-19 has been widely implemented PPV,studies showed an improvement in oxygenation in patients with ARDS(the P/F radio improved by more than 20% before and after PPV) was 9-77%, that is, That is, some patients are unresponsive to PPV. In addition, some patients showed CO2 responsiveness after PPV (ventilation rate (VR) decreased significantly after PPV).The tools for monitoring the effects of PPV on ventilation and blood flow at bedside are still lacking, Electrical impedance tomography (EIT) is a non-invasive, non-radiative, real-time bedside lung imaging technique that can monitor local lung ventilation distribution. By injecting hypertonic saline through a central vein catheter, we can obtain lung perfusion images to indicate local lung blood flow distribution. In addition, combined with lung ventilation images, we can evaluate the pulmonary shunt, dead space, V/Q ratio, to better clarify the physiological and pathological status of lung.This study intends to use EIT to evaluate pulmonary ventilation, blood flow distribution and local V/Q ratio before and after PPV, as well as to monitor the changes in pulmonary physiology before and after PPV, explore the mechanism of PPV improving oxygenation by combined with the changes in oxygenation, and explore the factors that predict and affect PPV responsiveness.

Study Type

Observational

Enrollment (Actual)

94

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Hubei
      • Wuhan, Hubei, China, 430000
        • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Patients who met inclusion exclusion criteria will implement EIT monitoring at the time of before the prone position, prone position for 16 hours and prone position ending 8h.

Description

Inclusion Criteria:

  • 1. Age ≥18 years. 2. Patients diagnosed with ARDS according to the Berlin definition and need to endotracheal intubated and mechanical ventilated in prone position within 48 hours of endotracheal intubation 3. PaO2/FiO2 < 150 mmHg with positive end-expiratory pressure (PEEP) ≥ 5 cmH2O according to the Berlin definition.

Exclusion Criteria:

  • 1. Contraindications of EIT such as chest wound dressing, installation of pacemaker, defibrillator, etc.

    2. Unstable vertebral fracture 3. Within 15 days after severe facial trauma or facial surgery 4 within 15 days after tracheal surgery or sternotomy 5. Hemodynamic instability or recent cardiac arrest 6. Increased intraocular pressure. 7. Unstable femoral or pelvic fractures and pelvic external fixation. 8 He had severe chest wall disease and unstable rib fractures. 9 Recent cardiothoracic surgery. 10. Pneumothorax 11. Chronic lung disease: severe obstructive pulmonary disease, severe asthma, interstitial lung disease.

    12. Maternal 13. Extracorporeal membrane oxygenation(ECMO) had been administered on admission to the ICU.

    14. Intracranial hypertension 15. Pulmonary embolism, acute or chronic right heart failure 16. Severe cardiac dysfunction (New York Heart Association class III or IV, acute coronary syndrome, or sustained ventricular tachyarrhythmia), cardiogenic shock; 17. No informed consent was obtained

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pulmonary ventilation perfusion(V/Q) ratio after 16 hours of PPV monitored by EIT
Time Frame: 16 hours after prone position ventilation
the V/Q radio were monitored by EIT after patients were implemented prone position ventilation(PPV) for 16h. The images of ventilation distribution were collected by EIT, and the images of perfusion distribution were collected by injected 10ml of 10% hypertonic saline through a central vein catheter during inspiratory hold or expiratory hold. The ventilation and perfusion images were analysed by specialized software to obtain the data of V/Q radio.
16 hours after prone position ventilation

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pulmonary ventilation perfusion(V/Q) ratio before PPV monitored by EIT before PPV
Time Frame: within 1 hour before preparing PPV
The V/Q radio were monitored by EIT before patients were implemented prone position ventilation(PPV). The images of ventilation distribution were collected by EIT, and the data of perfusion distribution were collected by injected 10ml of 10% hypertonic saline through a central vein catheter during inspiratory hold or expiratory hold. The ventilation and perfusion images were analysed by specialized software to obtain the data of V/Q radio.
within 1 hour before preparing PPV
Pulmonary ventilation perfusion(V/Q) ratio after PPV ending 8h monitored by EIT
Time Frame: 8 hours hours after prone position ventilation ending
the V/Q radio were monitored by EIT 8 hours after prone position ventilation ending.The images of ventilation distribution were collected by EIT, and the data of perfusion distribution were collected by injected 10ml of 10% hypertonic saline through a central vein catheter during inspiratory hold or expiratory hold. The ventilation and perfusion images were analysed by specialized software to obtain the data of V/Q radio.
8 hours hours after prone position ventilation ending
Pulmonary ventilation distribution before PPV, PPV for 16h and 8h after PPV ending
Time Frame: within 1hour before preparing PPV, 16 hours after and 8 hours after PPV ending
Pulmonary ventilation distribution were monitored by EIT before PPV, PPV for 16h and 8h after PPV ending. The images of ventilation distribution were collected by EIT and analysed by specialized software to obtain the data.
within 1hour before preparing PPV, 16 hours after and 8 hours after PPV ending
Pulmonary perfusion distribution before PPV, PPV for 16h and 8h after PPV ending
Time Frame: within 1 hour before preparing PPV, 16 hours after and 8 hours after PPV ending
The pulmonary perfusion distribution were monitored by EIT before PPV, PPV for 16h and 8h after PPV ending. The images of perfusion distribution were collected by injected 10ml of 10% hypertonic saline through a central vein catheter during inspiratory hold or expiratory hold. The perfusion images were analysed by specialized software to obtain the data of pulmonary perfusion distribution.
within 1 hour before preparing PPV, 16 hours after and 8 hours after PPV ending
Pulmonary shunt percentage before PPV, PPV for 16h and 8h after PPV ending
Time Frame: within 1 hour before preparing PPV, 16 hours after and 8 hours after PPV ending
The ventilation and perfusion images were analysed by specialized software to obtain the data of pulmonary shunt percentage.
within 1 hour before preparing PPV, 16 hours after and 8 hours after PPV ending
Pulmonary dead space percentage before PPV, PPV for 16h and 8h after PPV ending
Time Frame: within 1 hour before preparing PPV, 16 hours after and 8 hours after PPV ending
The ventilation and perfusion images were analysed by specialized software to obtain the data of pulmonary dead space percentage.
within 1 hour before preparing PPV, 16 hours after and 8 hours after PPV ending
Peak pressure before PPV, PPV for 16h and 8h after PPV ending
Time Frame: Within 1 hour before preparing PPV, 16 hours after and 8 hours after PPV ending
Peak pressure data were obtained from ventilators
Within 1 hour before preparing PPV, 16 hours after and 8 hours after PPV ending
Plat pressure before PPV, PPV for 16h and 8h after PPV ending
Time Frame: Within 1 hour before preparing PPV, 16 hours after and 8 hours after PPV ending
Plat pressure data were obtained from ventilators
Within 1 hour before preparing PPV, 16 hours after and 8 hours after PPV ending
Tidal volume before PPV, PPV for 16h and 8h after PPV ending
Time Frame: within 1 hour before preparing PPV, 16 hours after and 8 hours after PPV ending
Tidal volume data were obtained from ventilators
within 1 hour before preparing PPV, 16 hours after and 8 hours after PPV ending
Driving pressure before PPV, PPV for 16h and 8h after PPV ending
Time Frame: within 1 hour before preparing PPV, 16 hours after and 8 hours after PPV ending
Driving pressure(DP) data were obtained from ventilators
within 1 hour before preparing PPV, 16 hours after and 8 hours after PPV ending
Static compliance(Cs) before PPV, PPV for 16h and 8h after PPV ending
Time Frame: within 1 hour before preparing PPV, 16 hours after and 8 hours after PPV ending
Cs is equal to tidal volume divided by DP
within 1 hour before preparing PPV, 16 hours after and 8 hours after PPV ending
P/F ratio before PPV, PPV for 16h and 8h after PPV ending
Time Frame: within 1 hour before preparing PPV, 16 hours after and 8 hours after PPV ending
P/F ratio data were obtain from arterial blood gas analysis
within 1 hour before preparing PPV, 16 hours after and 8 hours after PPV ending
Carbon dioxide partial pressure(PaCO2) before PPV, PPV for 16h and 8h after PPV ending
Time Frame: within 1 hour before preparing PPV, 16 hours after and 8 hours after PPV ending
PaCO2 data were obtain from arterial blood gas analysis
within 1 hour before preparing PPV, 16 hours after and 8 hours after PPV ending
Ventilatory ratio(VR) before PPV, PPV for 16h and 8h after PPV ending
Time Frame: within 1 hour before preparing PPV, 16 hours after and 8 hours after PPV ending
VR=[minute ventilation (ml/min)×arterial partial tension of carbon dioxide (mmHg)] / [predicted body weight×100×37.5
within 1 hour before preparing PPV, 16 hours after and 8 hours after PPV ending
28 days mortality
Time Frame: From the day of enrollment to day 28
Mortality of from the day of enrollment to day 28
From the day of enrollment to day 28
Ventilator free days(VFD) within 28 days
Time Frame: From the day of enrollment to day 28
The number of ventilator free days for patients from enrollment day to day 28, if patients died within 28 days,VFD was equal to zero.
From the day of enrollment to day 28
Mortality in the ICU
Time Frame: From the day of enrollment to the day of transfer from the ICU or death,up to 90 days
Mortality in the ICU of all participants
From the day of enrollment to the day of transfer from the ICU or death,up to 90 days
Length of stay(LOS)
Time Frame: From the day of to the day of admitting to hospital to depart from the hospital or death,up to 90 days
LOS(length of stay) of hospital
From the day of to the day of admitting to hospital to depart from the hospital or death,up to 90 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Xiaojing zou, MD, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 30, 2023

Primary Completion (Actual)

June 1, 2025

Study Completion (Actual)

July 1, 2025

Study Registration Dates

First Submitted

December 13, 2023

First Submitted That Met QC Criteria

December 22, 2023

First Posted (Actual)

December 26, 2023

Study Record Updates

Last Update Posted (Estimated)

September 9, 2025

Last Update Submitted That Met QC Criteria

September 8, 2025

Last Verified

September 1, 2025

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Acute Respiratory Distress Syndrome

Subscribe